Rock Springs Capital Management LP Has $112.74 Million Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Rock Springs Capital Management LP reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 20.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 216,000 shares of the medical equipment provider’s stock after selling 54,000 shares during the period. Intuitive Surgical makes up 4.3% of Rock Springs Capital Management LP’s portfolio, making the stock its 2nd largest holding. Rock Springs Capital Management LP owned approximately 0.06% of Intuitive Surgical worth $112,743,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth about $25,000. Berbice Capital Management LLC bought a new stake in Intuitive Surgical in the 4th quarter worth approximately $26,000. BankPlus Trust Department purchased a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $28,000. Hurley Capital LLC bought a new position in shares of Intuitive Surgical during the 4th quarter valued at approximately $28,000. Finally, Summit Securities Group LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter valued at $30,000. 83.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms have commented on ISRG. CICC Research initiated coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They set a “neutral” rating and a $550.00 price objective for the company. Citigroup lifted their price target on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Royal Bank of Canada upped their price objective on Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Evercore ISI lifted their target price on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Finally, JPMorgan Chase & Co. increased their price target on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $611.81.

Intuitive Surgical Stock Up 0.3 %

Shares of NASDAQ ISRG opened at $482.74 on Monday. Intuitive Surgical, Inc. has a twelve month low of $364.31 and a twelve month high of $616.00. The firm has a market cap of $171.94 billion, a PE ratio of 75.31, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. The business has a fifty day simple moving average of $522.23 and a two-hundred day simple moving average of $532.71.

Insider Activity

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Jamie Samath sold 94 shares of the company’s stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at $1,502,019.30. The trade was a 3.45 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 33,754 shares of company stock worth $17,691,621. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.